Biomed Vision Technologies L.C.


BioMed Vision Technologies LC (BMVT) has a particular interest in the development of veterinary medical equipment for diagnosing ocular diseases and systems for drug delivery such as programmable pumps for ocular medications delivery in horses and dogs. BMVT is also in the process of developing software applications for electronic management of medical records.

BioMed Vision Technologies LC (BMVT) has a particular interest in the development of veterinary medical equipment for diagnosing ocular diseases and systems for drug delivery such as programmable pumps for ocular medications delivery in horses and do...Show all

Company (Alive / Active)

Phone:

Fax:

Ames, 50010
Iowa, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Biomed Vision Technologies L.C. $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Biomed Vision Technologies L.C. Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

The Liposome Company

United Kingdom
Alive / ActiveThe Liposome Company is developing liposome-based drug deliveryLogin to see details

Valeritas

Bridgewater, New Jersey, United States
IPO / Went publicValeritas is committed to developing and commercializing treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes. Valeritas' portfolio is headlined by the V-Go disposable insulin delivery device, which is being commercialized and reimbursed in a specialty pharmaceutical model and is distributed through retail pharmacy. In addition to the V-Go, Valeritas' delivery technology portfolio includes the h-Patch for ...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)